NEC Bio Therapeutics GmbH

NEC Bio Therapeutics, established in Manheim, Germany, focuses on the clinical strategy and development, as well as planning and execution of clinical trials in the oncology area. It is a subsidiary of NEC Bio, the biotech arm of NEC Corporation. NEC Bio, a subsidiary of NEC Corporation, is located in the Netherlands and dedicated to the development of innovative biotechnological solutions to tackle some of the most pressing health challenges. NEC Bio's research and development efforts are focused on creating personalized therapies that improve the quality of life for patients worldwide. NEC OncoImmunity in Oslo, Norway, is also a subsidiary of NEC Bio. *

	Start	2023-05-31 established
	Group	NEC (Group)
	Predecessor	Vaximm GmbH
	Industry	BIOTECH
	Person	Lubenau, Heinz (Vaximm 201101 Managing Director Vaximm GmbH before BioGeneriX before Servier)

	Region	Mannheim
	Country	Germany
	City	n. a. Mannheim
		Address record changed: 2024-08-09

Basic data	Employees	n. a.

		* Document for »About Section«: AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines".

		Record changed: 2024-08-09